Hudock Inc’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-350
Closed -$62K 711
2017
Q3
$62K Hold
350
0.03% 207
2017
Q2
$36K Hold
350
0.02% 274
2017
Q1
$27K Hold
350
0.01% 295
2016
Q4
$15K Hold
350
0.01% 345
2016
Q3
$19K Hold
350
0.01% 330
2016
Q2
$17K Hold
350
0.01% 357
2016
Q1
$16K Hold
350
0.01% 367
2015
Q4
$21K Hold
350
0.01% 307
2015
Q3
$19K Hold
350
0.01% 330
2015
Q2
$21K Hold
350
0.01% 322
2015
Q1
$20K Hold
350
0.01% 341
2014
Q4
$20K Hold
350
0.01% 321
2014
Q3
$10K Buy
+350
New +$8.66K 0.01% 396

Hudock Inc's KITE Position: Q4 2017 in Review

Hudock Inc sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 350 shares — an estimated $62K sold.

Hudock Inc first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $62K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Hudock Inc reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Hudock Inc sold 350 Kite Pharma, Inc. shares in Q4 2017, an estimated $62K.
  • Hudock Inc first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
  • Hudock Inc's Kite Pharma, Inc. position peaked at $62K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Hudock Inc's 13F filing for Q4 2017, filed 30 Jan 2018.